Wei Qian

Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021

Shaojie Jiang, Xiaoli Sun, Qing Wu, 2022, Journal of Hematology & Oncology.

Phase I study to evaluate of the gastric pH-dependent drug interaction between famitinib and the proton pump inhibitor omeprazole in healthy subjects

Ting Dou, Ming-min Cai, Wei Qian, 2022, Investigational New Drugs.

Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects

Ting Dou, Ming-min Cai, Wei Qian, 2023, Investigational New Drugs.

Test-retest reproducibility and gender differences in binding of CB1 PET tracer [11C]OMAR in humans

Yiyun Huang, R. Carson, J. Ropchan, 2010 .

Effects of rifampicin on antineoplastic drug pyrotinib maleate pharmacokinetics in healthy subjects

Ting Dou, Ming-min Cai, Wei Qian, 2022, Investigational new drugs.